Page 804 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 804

690    Part VI  Non-Malignant Leukocytes


         3.  Lanasa MC, Weinberg JB: Immunologic aspects of monoclonal B-cell   16.  Drewry AM, Samra N, Skrupky LP, et al: Persistent lymphopenia after
           lymphocytosis. Immunol Res 49(1–3):269–280, 2011.     diagnosis of sepsis predicts mortality. Shock 42(5):383–391, 2014.
         4.  Hudnall SD, Molina CP: Marked increase in L-selectin-negative T cells   17.  Fayaz  A,  Igoe  A,  Kurien  BT,  et al:  Haematological  manifestations  of
           in neonatal pertussis: The lymphocytosis explained? Am J Clin Pathol   lupus. Lupus Sci Med 2(1):e000078, 2015.
           114(1):35–40, 2000.                                18.  Shao L, Fujii H, Colmegna I, et al: Deficiency of the DNA repair enzyme
         5.  Walsh NP, Gleeson M, Shephard RJ, et al: Position statement. Part one:   ATM in rheumatoid arthritis. J Exp Med 206(6):1435–1449, 2009.
           Immune function and exercise. Exerc Immunol Rev 17:6–63, 2011.  19.  Prasad AS: Zinc in human health: effect of zinc on immune cells. Mol
         6.  Karandikar  NJ,  Hotchkiss  EC,  McKenna  RW,  et al:  Transient  stress   Med 14(5–6):353–357, 2008.
                                                                                                       +
           lymphocytosis:  an  immunophenotypic  characterization  of  the  most   20.  Zonios DI, Falloon J, Bennett JE, et al: Idiopathic CD4  lymphocyto-
           common  cause  of  newly  identified  adult  lymphocytosis  in  a  tertiary   penia:  natural  history  and  prognostic  factors.  Blood  112(2):287–294,
           hospital. Am J Clin Pathol 117(5):819–825, 2002.      2008.
         7.  Choi TS, Doh KS, Kim SH, et al: Clinicopathological and genotypic   21.  Robak T, Lech-Maranda E, Korycka A, et al: Purine nucleoside analogs
           aspects  of  anticonvulsant-induced  pseudolymphoma  syndrome.  Br  J   as immunosuppressive and antineoplastic agents: mechanism of action
           Dermatol 148(4):730–736, 2003.                        and clinical activity. Curr Med Chem 13(26):3165–3189, 2006.
         8.  Cornet E, Lesesve JF, Mossafa H: Long-term follow-up of 111 patients   22.  Fuks Z, Strober S, Bobrove AM: Long term effects of radiation of T and
           with persistent  polyclonal B-cell  lymphocytosis  with  binucleated lym-  B lymphocytes in peripheral blood of patients with Hodgkin’s disease. J
           phocytes. Leukemia 23(2):419–422, 2009.               Clin Invest 58(4):803–814, 1976.
         9.  Al-Herz W, Bousfiha A, Casanova J-L, et al: Primary immunodeficiency   23.  Hamblin AD, Hamblin TJ: The immunodeficiency of chronic lympho-
           diseases: an update on the classification from the International Union   cytic leukaemia. Br Med Bull 87:49–62, 2008.
           of Immunological Societies Expert Committee for Primary Immunode-  24.  Conley ME, Dobbs AK, Farmer DM, et al: Primary B cell immunode-
           ficiency. Front Immunol 5:1–33, 2014.                 ficiencies: comparisons and contrasts. Annu Rev Immunol 27:199–227,
        10.  Notarangelo LD, Miao CH, Ochs DH: Wiskott-Aldrich syndrome. Curr   2009.
           Opin Hematol 15:30–36, 2008.                       25.  Jolles S: The variable in common variable immunodeficiency: a disease of
        11.  Staples  ER,  McDermott  EM,  Reiman  A:  Immunodeficiency  in  ataxia   complex phenotypes. J Allergy Clin Immunol Pract 1(6):545–556, 2013.
           telangiectasia  is  correlated  strongly  with  the  presence  of  two  null   26.  Qamar N, Fuleihan RL: The  hyper  IgM syndromes.  Clin Rev Allergy
           mutations in the ataxia telangiectasia mutated gene. Clin Exp Immunol   Immunol 46(2):120–130, 2014.
           153:214–220, 2008.                                 27.  Moschese  V,  Graziani  S,  Avanzini  MA,  et al:  A  prospective  study  on
        12.  Dickinson  RE,  Milne  P,  Jardine  L,  et al:  The  evolution  of  cellular   children with initial diagnosis of transient hypogammaglobulinemia of
           deficiency in GATA2 mutation. Blood 123(6):863–874, 2014.  infancy: results from the Italian Primary Immunodeficiency Network.
                                        +
        13.  Stein DS, Korvick JA, Vermund SH: CD4  lymphocyte cell enumera-  Int J Immunopathol Pharmacol 21(2):343–352, 2008.
           tion for prediction of clinical course of human immunodeficiency virus   28.  Dispensieri  A,  Gertz  M,  Therneau  T,  et al:  Retrospective  cohort
           disease: a review. J Infect Dis 165(2):352–363, 1992.  study  of  148  patients  with  polyclonal  gammopathy.  Mayo  Clin  Proc
        14.  Yuen  KY,  Chan  PK,  Peiris  M,  et al:  Clinical  features  and  rapid  viral   76(5):476–487, 2001.
           diagnosis  of  human  disease  associated  with  avian  influenza  A  H5N1   29.  Ozen S, Bilginer Y: A clinical guide to autoinflammatory diseases: familial
           virus. Lancet 351(9101):467–471, 1998.                Mediterranean fever and next-of-kin. Nat Rev Rheumatol 10(3):135–147,
                                           +
        15.  Turett  GS,  Telzak  EE:  Normalization  of  CD4   T-lymphocyte  deple-  2014.
           tion  in  patients  without  HIV  infection  treated  for  tuberculosis. Chest   30.  Mosalpuria K, Bociek RG, Vose JM: Angioimmunoblastic T-cell lym-
           105(5):1335–1337, 1994.                               phoma management. Semin Hematol 51(1):52–58, 2014.
   799   800   801   802   803   804   805   806   807   808   809